个性化青光眼药物组合可降低眼压,并可能提高依从性和可负担性

D. Laroche
{"title":"个性化青光眼药物组合可降低眼压,并可能提高依从性和可负担性","authors":"D. Laroche","doi":"10.24966/OCR-8887/100085","DOIUrl":null,"url":null,"abstract":"We report results from four glaucoma patients on multiple topical medications who refused or failed interventional surgery and opted for in-office medication compounding (n=4). Topical medications with preservatives were compounded into one 10ml-bottle under sterile conditions. Patients used one drop of the compounded solution twice daily. Patients demonstrated significantly reduced IOP and self-reported better compliance after 3 months of use","PeriodicalId":91268,"journal":{"name":"HSOA journal of ophthalmology & clinical research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Personalized Glaucoma Medication Compounding Reduces Intraocular Pressure and May Increase Adherence and Affordability\",\"authors\":\"D. Laroche\",\"doi\":\"10.24966/OCR-8887/100085\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We report results from four glaucoma patients on multiple topical medications who refused or failed interventional surgery and opted for in-office medication compounding (n=4). Topical medications with preservatives were compounded into one 10ml-bottle under sterile conditions. Patients used one drop of the compounded solution twice daily. Patients demonstrated significantly reduced IOP and self-reported better compliance after 3 months of use\",\"PeriodicalId\":91268,\"journal\":{\"name\":\"HSOA journal of ophthalmology & clinical research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HSOA journal of ophthalmology & clinical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24966/OCR-8887/100085\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HSOA journal of ophthalmology & clinical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24966/OCR-8887/100085","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

我们报告了四名接受多种局部药物治疗的青光眼患者的结果,他们拒绝或失败了介入手术,并选择了办公室药物复合治疗(n=4)。在无菌条件下,将含有防腐剂的局部药物配制成一个10毫升的瓶子。患者使用一滴复方溶液,每天两次。患者在使用3个月后表现出明显的眼压降低和自我报告的更好的依从性
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Personalized Glaucoma Medication Compounding Reduces Intraocular Pressure and May Increase Adherence and Affordability
We report results from four glaucoma patients on multiple topical medications who refused or failed interventional surgery and opted for in-office medication compounding (n=4). Topical medications with preservatives were compounded into one 10ml-bottle under sterile conditions. Patients used one drop of the compounded solution twice daily. Patients demonstrated significantly reduced IOP and self-reported better compliance after 3 months of use
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信